Fractionated Gemtuzumab Ozogamicin Followed by Non-engraftment Donor Leukocyte Infusions for Relapsed/Refractory Acute Myeloid Leukemia
Clinical trial NCT03374332 · COMPLETED
Trial details
- NCT number
- NCT03374332
- Sponsor
- Brown University
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-31
- Primary completion
- 2023-09-26
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.